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Implications for
Nursing Care
The Pathophysiology of Sepsis
Lauren Tomczak, BSN, RN, CCRN, SRNA
Introduction
• Sepsis	is	a	life-threatening	organ	dysfunction	caused	by	simultaneous	systemic	inflammation	and	coagulation	in	response	to	microbial	infection	(Schub,	2018).
• Sepsis is a disease that has beenknown and studied for over 2000years yet there is still so much of itthat is not understood (Ward & Levy,2017).
• Sepsis	means	a	very	heterogenous	population,	which	varies	in	etiology	and	severity;	therefore,	universally	applicable	diagnostic	criteria	and	treatment	algorithms	are	difficult	to	be	defined	(Laszlo,	Trasy,	Molnar,	&	Fazakas,	2015).	
• Sepsis	is	associated	with	high	morbidity	and	mortality	and	accounted	for	$23.7	billion	in	healthcare	expenditures	in	2013	(McCance	&	Huether,	2019).	
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Significance of
Pathophysiology• Bacteremia:
• Gram-negative	organism	releases	endotoxin	
• Gram-positive	organism	releases	exotoxin
• Release of proinflammatorycytokines
• Activation of:
• Complement system
• Coagulation	system
• Kinin System
• Neutrophil,	endothelial,	and	monocyte-macrophage	activity
• Release of anti-inflammatorycytokines
• Endothelial cell dysfunction:
• Capillary leak
• Microvascular	thrombus
• Cell adhesion
• Tissue	hypoxia
• Impaired	vascular tone
• Free radical	damage
• Multiple organ	dysfunction:
• Altered mental	status
• PaO2/FiO2 <300;	tachypnea
• Urine <0.5mL/kg/hr
• Hypotension	with	tachycardia
• Thrombocytopenia;	↑	D-dimer
• Metabolic	acidosis;	↑	lactate	
• Poor capillary refill
• Death(McCance	&	Huether,	2019)
• In-depth and comprehensiveknowledge	on	the	immune	cell	activities	and	their	correlation	with	severity	of	sepsis	will	help	clinicians	and	scientists	design	effective	immunomodulatory	therapeutics	for	sepsis	(Bhan et	al.,	2016).	
• Delays in treatment directlyinfluence mortality in patientswith sepsis (Nagalingam, 2018).
• Sepsis is one of the most common	causes of death among ICUpatients worldwide (Schub,	2018).
• Prompt	recognition	of	sepsis	symptoms	and	treatment	initiation	are	essential	to	managing	septic	patients	(Schorr,	2018).
• A	guiding	principle	is	that	septic	patients	are	complex	and	need	detailed	initial	assessment	and	ongoing	reevaluation	of	their	response	to	treatment		(Schorr,	2018).
• Norepinephrine	is	considered	the	vasopressor	of	choice	in	septic	shock	(McCance	&	Huether,	2019).	
• Host-derived	molecules	and	foreign	products	of	infection	converge	on	molecular	mechanisms	that	cause	unbalanced	activation	of	innate	immunity.	Foreign	and	endogenous	molecules	interact	with	pathogen	recognition	receptors	expressed	on	or	in	the	immune	system.	Activation	of	pathogen	recognition	receptors	culminates	in	the	release	of	immune	mediators	that	produce	the	clinical	signs	and	symptoms	of	sepsis	(Ward	&	Levy,	2017).
• When	the	host	response	induced	against	a	local	infection	fails	to	contain	it	locally,	it	progresses	to	sepsis,	septic	shock,	and	death	(Bhan, Dipankar,	Chakraborty,	&	Sarangi,	2016).
• The	mortality	rate	is	20%	of	hospitalized	patients	with	sepsis	and	60-80%	of	patients	with	septic	shock (Schub,	2018).
• Restoration of hemodynamics in	septic	patients	does	not	always	prevent	or	repair	organ	dysfunction	(Ward	&	Levy,	2017).
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• Immunomodulation	strategies	
• Extracorporeal	removal	of	cytokines	via	the	addition	of	devices	to	hemofiltration	or	ECMO	circuits
• Low-dose glucocorticosteroids to	mitigate	the	inflammatory	process
• Intravenous	immunoglobulins	to	neutralize	endotoxins	
• Thiamine	supplementation	to	support	ATP	generation	via	the	Kreb’s cycle
• Vitamin	C,	vitamin	E,	selenium,	and	zinc	for	mitochondrial	protection,	improved	microcirculatory	flow,	and	restoration	of	endothelial	integrity		
• Coenzyme	Q10,	melatonin,	glutamine,	and	L-carnitine	to	assist	in	metabolic	resuscitation	and	reduce	oxidative	stress
• Gut	microbiome	mapping,	manipulation,	and	restoration
• Fecal transplantation	to	restore	gut	health	and	function
• Decatecholaminization with	cardio-selective	beta-1	adrenergic	blockers	and	alpha-2	adrenoreceptor	agonists
• Heparin	as	an	immunomodulator	and	antithrombotic	agent(Chausse,	Malekele,	&	Paruk,	2018)
Adjunct Therapies
Cellular Level
Pathophysiology
Treatment
• Patients	in	septic	shock	have	improved	outcomes	if	antibiotics	are	administered	within	the	first	hour	of	diagnosis	(Nagalingam,	2018)
• Nurses	are	instrumental	to	improving	outcomes	for	patients	with	sepsis	of	septic	shock	(Schorr,	2018)
• Nursing responsibilities include:	collecting	blood	and	urine	specimens;	assessing	the	patient	for	hemodynamic	instability;		assessing	for	and	managing	pain;	administering	IV	fluid	resuscitation,	antibiotics,	corticosteroids,	and	vasopressor	medications;	monitoring	intake,	output,	vital	signs,	laboratory	and	diagnostic	results	(Schub,	2018)
Figure 2.	Select mechanisms	implicated	in	the	pathogenesis	of	sepsis-induced	
organ	and	cellular	dysfunction	(Seymour	&	Angus,	2018).
Signs and Symptoms
• Fever >38.3ºC	(100.4ºF)
• Hypothermia <36º	C	(96.8ºF)
• Tachycardia:	HR	>90	bpm
• Tachypnea:	RR	>30	bpm
• Progressive deterioration ofmental status
• Altered	mental	status
• Significant edema of positive fluidbalance (>20mL/kg	over	24	hr)
• Hyperglycemia (BG	>140	mg/dL	in	the	absence	of diabetes)
• Leukocytosis:	WBC	>12,000/mm3
• Leukopenia: WBC <4000/mm3
• Normal WBC with >10% bands
• CRP	>2	SD	above	normal	value
• PCT	>2	SD	above	normal	value
• Arterial hypotension (SBP	<90	mmHg;	MAP	<70	mmHg;	SBP	decrease	>40	mmHg)
Case Presentation
• SvO2 >70%
• Cardiac	index	>3.5L/min
• Arterial	hypoxemia (PaO2/FiO2<300 mmHg)
• Acute oliguria (urine output	<0.5	mL/kg/hr for	at	least	2	hr)
• Creatinine increase >0.5 mg/dL
• Coagulation abnormalities (INR>1.5 or PTT >60 seconds)
• Ileus
• Thrombocytopenia (platelet count<100,000/m3)
• Hyperbilirubinemia (plasma totalbilirubin >4 mg/dL or	70	mmol/L)
• Hyperlactatemia (>1 mmol/L)
• Decreased capillary refill or	mottling(McCance	&	Huether,	2019)
Figure	3.	The goal of the Surviving Sepsis Campaign (SSC) is to begin
resuscitation and management immediately	(Schorr,	2018).
Figure	1.	Think	sepsis.	Act	fast.	
Time	matters	(Ward & Levy,	
2017).
